Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 11/20 | 0.60 |
| ▸ | KDR | P35968 | 7/20 | 0.58 |
| ▸ | CDK8 | P49336 | 2/20 | 0.58 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.58 |
| ▸ | RET | P07949 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | PLK4 | O00444 | 1/20 | 0.58 |
| ▸ | CIT | O14578 | 1/20 | 0.58 |
| ▸ | AURKA | O14965 | 1/20 | 0.58 |
| ▸ | MUSK | O15146 | 1/20 | 0.58 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.58 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.58 |
| ▸ | MLNR | O43193 | 1/20 | 0.58 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.58 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.58 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.58 |
| ▸ | PDE6D | O43924 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | STK10 | O94804 | 1/20 | 0.58 |
| ▸ | CDK14 | O94921 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29733289 | 0.94 | RAF1 (0.67) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL548256 | 0.94 | RAF1 (0.67) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL14714846 | 0.92 | KDR (0.62) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL548163 | 0.89 | RAF1 (0.64) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL14680381 | 0.88 | RAF1 (0.54) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL549150 | 0.87 | RAF1 (0.56) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL14680565 | 0.86 | RAF1 (0.56) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL29746661 | 0.86 | KDR (0.68) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL15114776 | 0.86 | KDR (0.68) | RAF1KDRCDK8AURKBRET | |
| SCHEMBL549118 | 0.83 | RAF1 (0.65) | RAF1KDRCDK8AURKBRET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3330254-A2 | METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED OMEGA-DIPHENYLUREA | Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) | 2018-06-06 | — | — | EP | disclosed |
| EP-2548868-B1 | METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED OMEGA -DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) | 2018-01-24 | — | — | EP | disclosed |
| US-9078933-B2 | Deuterated omega diphenylurea related compounds and intermediates | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2015-07-14 | — | — | US | disclosed |
| US-9072796-B2 | Method for preparing deuterated diphenylurea | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2015-07-07 | — | — | US | disclosed |
| US-20150175545-A1 | Preparation Method of Fluoro-Substituted Deuterated Diphenylurea | SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) | 2015-06-25 | — | — | US | disclosed |
| EP-2548859-B1 | PREPARATION METHODS OF METHYL-D3-AMINE AND SALTS THEREOF | SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD (CN) | 2015-03-04 | — | — | EP | disclosed |
| US-8759531-B2 | Preparation method of fluoro-substituted deuterated diphenylurea | Suzhou Zelgen Biopharmaccceutical Co., Ltd. (CN) | 2014-06-24 | — | — | US | disclosed |
| US-8748666-B2 | Preparation methods of methyl-D3-amine and salts thereof | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2014-06-10 | — | — | US | disclosed |
| US-20140128612-A1 | DEUTERATED OMEGA DIPHENYLUREA RELATED COMPOUNDS AND INTERMEDIATES | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2014-05-08 | — | — | US | disclosed |
| US-20140088311-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2014-03-27 | — | — | US | disclosed |
| US-20130060044-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2013-03-07 | — | — | US | disclosed |
| US-20130060044-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2013-03-07 | — | — | US | disclosed |
| US-20130060043-A1 | PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD (CN) | 2013-03-07 | — | — | US | disclosed |
| US-20130035492-A1 | METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED OMEGA-DIPHENYLUREA | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. | 2013-02-07 | — | — | US | disclosed |
| EP-2548859-A1 | PREPARATION METHODS OF METHYL-D3-AMINE AND SALTS THEREOF | Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) | 2013-01-23 | — | — | EP | disclosed |
| EP-2548867-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) | 2013-01-23 | — | — | EP | disclosed |
| EP-2548868-A1 | METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED -DIPHENYLUREA | Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) | 2013-01-23 | — | — | EP | disclosed |
| US-20130018209-A1 | PREPARATION METHODS OF METHYL-D3-AMINE AND SALTS THEREOF | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2013-01-17 | — | — | US | disclosed |
| US-20130012548-A1 | DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2013-01-10 | — | — | US | disclosed |
| US-20130012548-A1 | DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS | SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130060043-A1 | PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA | CCND3, UBE2D3, VDR | RAF1 3715/4885KDR 4466/4885CDK8 370/4885 |
| US-20140088311-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | NMUR1, NMUR2, NUDT1 | RAF1 4326/4885KDR 4744/4885CDK8 976/4885 |
| US-20130012548-A1 | DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS | PPARD, HDHD5, SCD | RAF1 2908/4885KDR 1916/4885CDK8 975/4885 |
| US-20130035492-A1 | METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED OMEGA-DIPHENYLUREA | PNLIP, PDXK, PNP | RAF1 1962/4885KDR 3367/4885CDK8 76/4885 |
| US-20140128612-A1 | DEUTERATED OMEGA DIPHENYLUREA RELATED COMPOUNDS AND INTERMEDIATES | PNLIP, PDXK, DGKK | RAF1 1043/4885KDR 3962/4885CDK8 71/4885 |
| US-20130018209-A1 | PREPARATION METHODS OF METHYL-D3-AMINE AND SALTS THEREOF | NSD3, CCND3, DRD3 | RAF1 4408/4885KDR 4053/4885CDK8 333/4885 |
| US-20150175545-A1 | Preparation Method of Fluoro-Substituted Deuterated Diphenylurea | CCND3, UBE2D3, VDR | RAF1 3715/4885KDR 4466/4885CDK8 370/4885 |
| US-20130060044-A1 | METHOD FOR PREPARING DEUTERATED DIPHENYLUREA | NMUR1, NMUR2, NUDT1 | RAF1 4326/4885KDR 4744/4885CDK8 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.